Facebook
Twitter
LinkedIn
ForwardSeattle Multidisciplinary Lung Cancer Conference
This accredited continuing education activity “Seattle Multidisciplinary Lung Cancer Conference”, will feature leading experts in lung cancer who will provide a comprehensive overview recent advances and controversies in management of lung cancer. The goal of this activity is to improve the knowledge, competence and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for their patients with lung cancer. Expert faculty will place key abstract findings from 2021 ASCO Annual Meeting (ASCO2021) and the IASLC 2021 World Conference on Lung Cancer (WCLC2021) into clinical context and discuss how the results may change the current standard of care.
Conference highlights:
- Innovative and integrated learning environment.
- Audience response system
- Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
- Opportunities to network with colleagues and interact with faculties; enduring materials allow learners opportunities to learn at their convenience.
- Program topics can immediately be applied to clinical practice.
Target Audience
This activity is directed towards clinical care team who treat patients with lung cancer:
- Oncologists
- Oncology fellows
- Oncology nurses
- Oncology nurse practitioners
- physician assistants,
- Oncology pharmacists
Learning Objectives
At the conclusion of the activity, participants will be able to:
- Review potentially practice changing abstracts presented at 2021 ASCO Annual Meeting (ASCO2021) and the IASLC 2021 World Conference on Lung Cancer (WCLC2021)
- Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in standards of care in lung cancer
- Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact management of patients with lung cancer
- Integrate emerging evidence into treatment paradigms for treatment of lung cancer.
COVID-19 Precautions
COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in.
Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.
Conference Chair: Dr. Joseph Rosales
All times are listed in pacific time zone.
06:30 AM to 07:45 AM PST - Registration/Networking
07:45 AM to 08:00 AM PST - Opening Remarks
08:00 AM to 09:45 AM PST: Diagnosis/Next generation sequencing
Moderator: Dr. Andrea Veatch
08:00 AM – 08:20 AM PST: Precision oncology – best practices in tissue/blood testing Dr. Tejas Patil
08:20 AM – 08:40 AM PST: Detection & Clinical Application of Minimal Residual Disease in Lung Cancer Dr. Jack West
08:40 AM – 09:00 AM PST: Pathologic assessment of NSCLC after neoadjuvant therapy Dr. Haodong Xu
09:00 AM – 09:45 AM PST: Case-based Discussion Dr. Andrea Veatch
09:45 AM to 10:15 AM PST: BREAK & EXHIBITS/PRODUCT THEATER
*9:45 AM to 10:15 AM - Breakfast & Learn in Parkside Room
Retevmo® (selpercatinib): A precision-based therapy for certain RET-driven cancers.
VISIT RETEVMO.COM/TEST TO LEARN MORE ABOUT TESTING METHODS FOR THIS ACTIONABLE BIOMARKER
*This activity is sponsored by Lilly Oncology and is not part of the CME program
10:15 AM to 12:00 PM PST: Resectable non-small cell lung cancer
Moderator: Dr. Joseph Rosales
10:15 AM – 10:35 AM PST: Sublobar resection in NSCLC Dr. Madhan Kuppusamy
10:35 AM – 10:55 AM PST: Beyond chemotherapy – adjuvant targeted therapy in NSCLC Dr. Sandip Patel
10:55 AM – 11:15 PM PST: Checkpoint inhibitors in neoadjuvant/adjuvant role in NSCLC Dr. Christina Baik
11:15 AM – 12:00 PM PST: Case-based discussion Dr. Joseph Rosales/Dr. Jed Gorden
12:00 PM – 13:00 PM PST: POSTER SESSION/LUNCH/EXHIBITS/PRODUCT THEATER
*12:00 to 12:30 PM in Parkside Room (2nd Floor) - Lunch and Learn with Dr. Hatin Husain, Medical Oncologist at the University of California San Diego.
EGFR EXON 20 INSERTION MUTATIONS - EMERGING IMPLICATIONS FOR THE MANAGEMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)
Visit https://www.rybrevanthcp.com to learn more about this product.
*This activity is sponsored by Janssen Biotech and is not part of the CME activity
13:00 PM – 15:00 PM PST: Unresectable/metastatic non-small cell lung carcinoma
Moderator: Dr. John Paul Flores
13:00 PM – 13:20 PM PST: Molecular directed therapy of advanced NSCLC in 2021 Dr. Kathryn Gold
13:20 PM – 13:40 PM PST: Antibody-drug conjugates in NSCLC Dr. Rafael Santana-Davila
13:40 PM – 14:00 PM PST: Emerging biomarker targets for checkpoint inhibitor therapy Dr. Wade T. Iams
14:00 PM – 14:45 PM PST: Case-based Discussion Dr. Jaideep Shenoi/Dr. John Paul Flores
14:45 PM – 15:15 PM PST: BREAK & EXHIBITS
15:15 PM – 17:00 PM PST: Small cell lung carcinoma/mesothelioma
Moderator: Dr. Joseph Rosales
15:15 PM – 15:35 PM PST: Surgery vs radiation in early-stage small cell lung cancer Dr. Adam Bograd
15:35 PM – 15:55 PM PST: Immunotherapy and targeted therapy in small cell lung cancer Dr. Renato G. Martins
15:55 PM – 16:15 PM PST: Pulmonary neuroendocrine tumors - recent updates Dr. Aman Chauhan
16:15 PM – 17:00 PM PST: Case-based discussion Dr. Joseph Rosales
A limited number of rooms have been reserved at a discounted rate of $159/night for use by the participants of this conference.
You must mention Binaytara Foundation/Lung Cancer Symposium while booking to receive the discounted group rate. Follow the link below or call 1-888-233-9527 to book your room.
All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. If a guest does not cancel a reservation by 6pm the day of arrival, then Hotel may charge the credit card one night’s room fee plus any applicable taxes.
TEJAS PATIL, MD Assistant Professor Medicine University of Colorado Hospital | MADHAN KUPPUSAMY, MD, FRCS Thoracic Surgery Virginia Mason Medical Center | ANDREA VEATCH, MD Hematologist/Oncologist Northwest Medical Specialties Puyallup | Assistant Professor of Medicine Vanderbilt University Medical Center |
JOSEPH ROSALES, MD Oncologist Virginia Mason Medical Center | Thoracic Surgeon Swedish Issaquah Hospital | Pulmonologist Swedish Medical Center | JED GORDEN, MD Pulmonologist Swedish Medical Center |
JACK WEST, MD Medical Oncologist City of Hope Comprehensive Cancer Center | YOSHIO INOUE, MD Medical Oncology The Everett Clinic - Providence Regional Cancer Partnership | AMAN CHAUHAN, MD Assistant Professor of Medicine UK Markey Cancer Center | HAODONG XU, MD, PhD Professor University of Washington School of Medicine |
SANDIP PATEL, MD Medical Oncologist Associate Professor of Medicine Moores Cancer Center at UC San Diego Health | KATE GOLD, MD Medical Oncologist Associate Professor of Medicine Moores Cancer Center at UC San Diego Health |
|
|
CHRISTINA BAIK, MD, MPH Physician Seattle Cancer Care Alliance Associate Professor, Medicine University of Washington School of Medicine Associate Professor, Clinical Research Division Fred Hutchinson Cancer Research Center | Medical Director, Infusion and Pharmacy Services Seattle Cancer Care Alliance Associate Professor, Medicine and Oncology University of Washington School of Medicine Physician UW Medicine Associate Professor, Clinical Research Division Fred Hutchinson Cancer Research Center |
CME/CE Information:
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Contact Hours:
Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
ABSM Maintenance of Certificate Recognition Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Acknowledgment of commercial support
This activity has been supported with independent medical education grant(s) from the following companies:
- Pfizer, Inc.
- AstraZeneca
- Regeneron
- Exact Sciences
- Jazz Pharmaceuticals
Available Credit
- 7.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 7.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
Please visit our exhibitors and product theater sponsors in the exhibit hall - Yellowstone Room.
The Product Theaters are in Parkside Room (2nd Floor by the elevator).
Breakfast and Lunch will be available in the Parkside Room and Exhibit Hall during the designated hours.
Price
COVID-19 Precautions
COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in.
Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.
Registration Fees
Physicians (MD/DO) - $125
Non-Physician (RN/NP/PA/PharmD) - $75
Residents/Fellows - $50
Industry representative - $550
Displaying company representative (not covered by the display fee) - $450.
If you want to register to attend only, and do not need CME/CE credits, please sign up using this form - Attend only registration
If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients.
CANCELLATION POLICY
You may cancel your enrollment at any time. cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is cancelled by August 15, 2021.
- No refunds will be issued if registration is cancelled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.